Objective: The aim of this study was to examine fetal and neonatal outcomes in the setting of nuchal translucency (NT) X3 mm at routine first-trimester screening.
Introduction
During 11 to 14 weeks of gestation, sonographic measurement of nuchal translucency (NT) thickness is a widely used and sensitive screening method for chromosomal abnormalities. 1 Some recent studies aimed to determine whether there is a NT measurement above which immediate invasive testing should be recommended, regardless of serum testing and computerized aneuploidy risk assessment. 2 In normal fetuses, NT thickness increases with fetal crown-rump length (CRL). The 99th percentile does not show any significant change with CRL, though it was about 3.5 mm in previous studies. 3 Fetal NT X3 mm has been used for pregnancy outcome evaluation in several studies. Adverse outcomes varied from 43 to 75%, using a cut-off value of 3 to 5 mm. [4] [5] [6] [7] Pregnancies affected by genetic syndromes are also associated with an increased risk of major fetal anomalies and specific ultrasound markers. These markers ('soft markers') are minor anomalies, possibly transient, with a little or no pathological significance, detected during the second-trimester ultrasound scan. For all patients having these markers, routine karyotyping is not recommended. 8 In a low-risk population, the outcomes of pregnancies with increased fetal NT (X3 mm) during the routine first-trimester prenatal screening were evaluated. The aim of this study was to find out the significance of the presence of structural changes and soft markers in a fetus with increased NT at first-trimester sonographic examination.
Methods
We conducted a nested case-series study within a retrospective cohort of unselected women with viable singleton pregnancies at 11 to 14 weeks of gestation were included in this study (from April 2004 to January 2007 at Perinatal Unit of the Haseki Training and Research Hospital). All scans were performed using a curvilinear transabdominal 3.5 to 5.0 MHz probe, and a 6.0 MHz transvaginal probe (Logic 400). Demographic details and ultrasound findings, CRL, NT thickness and fetal anomalies were noted at the time of the scan.
NT was defined as the presence of a thin translucent area lying between the inner surface of the skin and the soft tissue interface overlying the cervical spine. The maximal NT thickness was measured on a sagittal section of the fetus. During the scan, at least three measurements were taken and the largest one was recorded. A measurement X3 mm was considered as 'enlarged'.
Cases with a NTX3 mm were further counseled about the risk of chromosomal abnormality and, at second trimester, they took prenatal diagnosis by fetal karyotyping. In all cases with an evidence of enlarged NT, a detailed ultrasound scan was performed transvaginally and, at 15 weeks of gestation, sonographic examination was repeated. At 20 weeks of gestation, the group with no chromosomal anomalies was further investigated using detailed ultrasound examination and screened for maternal toxoplasmosis, cytomegalovirus, rubella virus and herpes virus. For each case, follow-up was obtained from the patients and medical records. Adverse outcomes were fetal death and termination of pregnancy due to structural or chromosomal anomaly.
The study protocol was approved by our hospital institutional review board. Fisher's exact was used to compare the groups with and without additional anomaly. A P-value <0.05 was considered statistically significant.
Results
A total of 1930 women participated in the study. An enlarged NT (mean 4.6 mm, range 3 to 9.3 mm) was detected in 27 fetuses (1.4%). An abnormal karyotype was diagnosed in nine fetuses (33.3%). Among these fetuses, 15 (55%) showed additional structural abnormalities while 12 had none. The rate of aneuploidy was significantly higher in the group with anomalies at 60% (9/15) as compared to the fetuses without additional anomalies, none of which were noted to have aneuploidy (0/12, P ¼ 0.002). The number of cases with maternal age >35 did not significantly differ between the groups.
Of the cases, three were hydropic and two had joint contractures at first examination. The absence of nasal bone was an additional sonographic finding in three fetuses at first-trimester scanning. Ventricular septal defect was detected in one of the cases with transvaginal sonographic examination. All cases with abnormal karyotype were in this group, having an incidence of chromosomal abnormality of 60%. Details on the type of malformations and prognosis are reported in Table 1 .
Of all cases with normal karyotype, six (35%) were found to have anomalies at sonographic examination performed during the first and second trimester. All of these cases with various malformations were terminated. The incidence of adverse outcome among patients with normal karyotype was 41% (7 of 17 cases).
Of 12 cases without additional abnormalities, two experienced fetal demise (one case at second trimester and one case at third trimester). In this group, the incidence of adverse outcome was 16%. In one case, fetal karyotype analysis was found to be normal. The other one refused to undergo invasive tests. In all surviving babies, NT resolved by 20 weeks of gestation and, thereby, postnatal examinations gave normal results. For all cases with increased fetal NT, total incidence of adverse outcome was 62%.
Discussion
A high correlation between increased NT and trisomy 21 and other chromosomal defects was reported. 9 The combination of NT with maternal serum markers such as PAPP-A and free -HCG was demonstrated to be more efficient in first-trimester screening. 10 Comstock et al. 2 found a 1 in 6 likelihood of fetal aneuploidy in the presence of a NT measurement X3.0 mm and concluded that it would be reasonable to perform immediate invasive testing on all such patients, regardless of obtaining serum markers. In previous reports using the same value (NT X3 mm), chromosomal abnormality rates ranged from 16.6 to 48% (Table 2 ). Other reports indicated that the risk of aneuploidy increases with increased fetal NT. For the cases with NT >5 mm, chromosomal abnormality rate was found to be 75%. 10 In this study, we found a high risk (33%) of chromosomal abnormality in cases with NT X3 mm. For the fetuses with increased NT and additional anomalies, the risk was higher (60%).
In a previous study, the most frequently encountered structural defect was a cardiac defect. 7 In chromosomally normal fetuses with enlarged NT, pathological examination of the heart and/or great arteries demonstrated a high incidence of abnormalities (90%), such as septal or valvular defects (43%), aortic isthmus narrowing and narrowing of the area just above the aortic valve (86%).
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The cardiac function in structurally and chromosomally normal fetuses with increased NT was also evaluated in a previous study which showed findings suggestive of cardiac diastolic dysfunction. 12 In the group of fetuses with isolated enlarged NT, the high fetal loss rate (16%) may be the result of undetected cardiac function anomalies. It might be worthwhile to perform fetal cardiac echography on the fetuses with increased NT (>3.5 mm), as stated in previous studies. 13 In a study conducted by Senat et al., 14 6.4% of the fetuses with no abnormality on follow-up ultrasound scan had a malformation diagnosed only at birth. Detailed postnatal examinations should be performed in all of the cases increased NT. In our cases, the most common anomaly seen with increased NT was mild renal pelviectasis. It often occurs in second-trimester fetuses most of which would not present clinically significant renal abnormalities after birth. As a marker for Down syndrome, the reported relative risk of pyelectasis was 1.5 times higher than a priori risk. 15 Although pyelectasis is considered as a soft marker, it can be worthwhile for the detection of Down syndrome when it is used in combination with increased NT.
An echogenic intracardiac focus (EIF) represents microcalcification in the papillary muscle or chordae tendinae of the fetal heart and is commonly associated with normal fetuses. 16 Calcification of the papillary muscle was reported in 39% of abortus Increased nuchal translucency B Dane et al with trisomy 13, 16% of those with trisomy 21 and 2% of normal abortus. 17 In a previous study, increased NT observed at first trimester was found to be associated with the presence of the second-trimester EIF. For these fetuses, the prevalence was reported to be 8.1%. 18 In three of our cases (11%), an echogenic intracardiac focus was detected at early second-trimester sonographic examination. All of these fetuses were found to have chromosomal abnormality.
Brachycephaly is characterized by relative shortening of the occipito-frontal diameter. Although it is well recognized that children with Down syndrome have brachycephaly during the postnatal life, prenatal ultrasonographic studies showed no 19 In two of our cases with Down syndrome, brachycephaly was an additional sonographic finding.
Nasal bone hypoplasia, defined as an invisible nasal bone or a nasal bone <2.5 mm, is described as a second-trimester ultrasound marker that is likely to have a major impact on screening for trisomy 21. 20 In three of our cases with Down syndrome (60%), the nasal bone was not visible at first-trimester screening.
In previous studies, pregnancies with septated cystic hygromas showed at least 50% likelihood of being aneuploid and required immediate invasive testing. 21 In a recent study, septations within the translucency were observed in all fetuses during the first trimester and it was concluded that this feature cannot be used to distinguish between increased NT and cystic hygromas. 22 In our study, the cases with septations within the translucency were included in both groups according to the presence of additional anomalies. For only one case with normal karyotype, which subsequently experienced fetal demise, nuchal edema and septations remained at second trimester (Figure 1) .
Among the fetuses without chromosomal anomaly, two were found to have ascites and joint contractures. Although prenatal diagnosis of congenital lethal arthrogryposis is based on the demonstration of multiple joint contractures, it may not become apparent until the end of the second trimester. In a previous study, 26% of these cases were found to have nuchal edema, and thereby, it was concluded that some of these cases may have increased NT at 10 to 14 weeks of gestation. 23 For a case with increased NT, fetal movement and posture of the joints should be examined.
The small sample size leading to inadequacy of conducting stratified analyses was one of the limitations of our study. Multicenter studies combining first and second-trimester sonographic examinations might provide larger number of cases and high statistical power. With retrospective collection of the data some of the fetuses with anomaly might be missed due to late occurrence or lack of the sonographic findings of the particular anomaly. Termination or delivery of the cases in the same center and performing detailed postnatal examinations might reduce the number of the missing cases and anomalies. However there still will be diagnostic bias in the study due to the termination of the cases before the formation of some anomalies (for example, cystic hygroma, ventriculomegaly).
In this study, of 27 pregnancies with an increased fetal NT, 17 (62%) presented an adverse outcome, comparably with outcomes from most of the other studies reviewed (Table 2) . First-trimester NT screening is an important part of the pregnancy follow-up. For a case which showed increased NT (X3 mm) at first-trimester screening, detailed ultrasonographic examination should be repeated at early second trimester to diagnose additional minor and major anomalies. In the presence of these anomalies, the risk of chromosomal abnormality is high. Further, prenatal surveillance and postnatal examinations are required in cases without anomalies.
